GSK Company Profile and Key Details

NYSE : GSK

GSK

$56.69

0.7+1.25%

At Close 4:00 PM

63.6

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

GSK plc (GSK) stock surged +1.25%, trading at $56.69 on NYSE, up from the previous close of $55.99. The stock opened at $55.56, fluctuating between $55.56 and $57.18 in the recent session.

Stock Snapshot

55.99

Prev. Close

113.68B

Market Cap

55.56

Day Low

15.45

P/E Ratio

3.67

EPS (TTM)

1.04

Cash Flow per Share

55.56

Open

2.01B

Number of Shares

57.18

Day High

95.9%

Free Float in %

3.29

Book Value

3.54M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	56.01	57.18	55.93	56.69	3.86M
Apr 01, 2026	55.52	56.46	55.41	55.99	6.25M
Mar 31, 2026	54.74	55.25	54.37	55.19	5.53M
Mar 30, 2026	54.64	54.65	54.07	54.23	3.34M
Mar 27, 2026	54.23	54.75	53.79	53.84	3.03M
Mar 25, 2026	54.39	54.98	54.07	54.70	5.31M
Mar 24, 2026	51.79	53.10	51.71	52.95	4.78M
Mar 23, 2026	52.19	52.69	51.80	51.99	4.33M
Mar 20, 2026	52.17	52.40	51.55	51.84	4.64M
Mar 19, 2026	51.72	52.69	51.65	52.37	3.97M
Mar 18, 2026	52.88	52.88	51.78	52.06	4.65M
Mar 17, 2026	53.73	53.99	53.37	53.41	3.22M
Mar 16, 2026	54.21	54.58	53.70	53.77	4.15M
Mar 13, 2026	54.48	54.73	53.37	53.39	4.66M
Mar 12, 2026	54.57	54.57	53.77	54.28	5.33M
Mar 11, 2026	55.30	55.56	54.79	55.15	5.4M
Mar 10, 2026	55.53	56.05	55.10	55.32	5.13M
Mar 09, 2026	54.36	55.58	53.92	55.51	5.97M
Mar 06, 2026	54.41	54.92	54.07	54.51	6.19M
Mar 03, 2026	56.82	57.35	56.16	57.07	3.85M

Contact Details

Brentford, TW8 9GS

United Kingdom

https://www.gsk.com 442 080 475000

About Company

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

Stock Peers

LLY

-18.9-1.98%

Eli Lilly and Company$935.62 JNJ

-1.08-0.44%

Johnson & Johnson$243.04 ABBV

-6.185-2.88%

AbbVie Inc.$208.80 AZN

2.76+1.37%

AstraZeneca PLC$203.49 NVS

-1.05-0.68%

Novartis AG$154.03 MRK

0.03+0.02%

Merck & Co., Inc.$120.87 BMY

-2.13-3.45%

Bristol-Myers Squibb Company$59.60 NVO

0.495+1.36%

Novo Nordisk A/S$36.98 PFE

-0.22-0.77%

Pfizer Inc.$28.33 OGN

0.22+3.58%

Organon & Co.$6.36

Company Overview

GSK plc (NYSE:GSK) closed at $56.69 USD, gaining $0.70 (1.25%) from the previous close of $55.99. The stock is currently mid-range between its 52-week high and low $32.38 and $61.70. With a market capitalization of about $113.68 billion, GSK plc is classified as a large-cap and shows lower-than-market volatility (beta ~0.35). Key stats such as the average daily volume over the past year has been around 5.59 million shares, volume is running light vs its 52-week average. Headquartered in Brentford, None, GSK plc operates in the Healthcare sector and the Drug Manufacturers - General industry. Led by CEO Luke Victor Miels, the company employs approximately 68,629 people and listed since March 28, 1980. GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 0.38%, SMA50 10.09%, SMA200 30.88%). The stock’s 14-day RSI is 57.8 (neutral), while the ATR of 1.15 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -5.88% below its high and over 79.32% above its low. Average 10-day trading volume of 4.59 million shares is below the 3-month average of 5.57 million, indicating normal recent market interest.

Valuation Metrics

GSK plc trades at a P/E ratio of 15.11, slightly below the S&P 500 average, with a price-to-sales ratio of 2.65 and a price-to-book ratio of 5.28 trading at moderately above to book value. The P/FCF stands at 13.88, also below market averages.

Dividend & Fair Value

GSK plc last paid a dividend of 1.76 per share, this equals a trailing yield of roughly 1.46%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $106.86. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

GSK plc generated EPS of $3.66 over the past year. Five-year average earnings growth is 0.08%. Wall Street analysts project EPS growth of 6.19% annually over the next five years. The latest quarter delivered EPS of $1.46. The next quarter is forecast at $1.17. Next year's EPS is expected at $0.56. GSK plc earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 29, 2025, missed forecasts by 15.87%. The prior quarter beat by 9.82%. Over the last six quarters, Apple has recorded several small beats. These include 9.0% in July 31, 2024.

Shareholding & Insider Activity

GSK plc has 2.01 billion shares outstanding. The public float is 3.91 billion shares, elevated short interest at 0.62% of float. This equals 12.53 million shares. The short ratio is 2.04 days. Institutional investors hold 19.1% of the float. Insiders own 0.06%.

Financial & Profitability Overview

Over the trailing twelve months, GSK generated $30.33B in revenue, or $7.38 per share. Gross margin was 70.07%, operating margin 23.06%, and net profit margin 16.25%. Returns are healthy, with ROA at 8.35% and ROE at 36.92%.
On valuation metrics, GSK trades at a P/E of 15.11, P/S of 2.65 and P/B of 5.28. Liquidity is tight, with a current ratio of 0.82 and quick ratio of 0.54. Operationally, the company’s inventory turnover is 1.52 and cash conversion cycle is -297.83 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 1.08, supported by a cash flow-to-debt ratio of 0.47.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, GSK posted revenue of $30.33B, down slightly from $29.32B in the prior quarter. Gross profit was $21.25B (margin 70.07%). Operating income was $6.99B (margin 23.1%). Net income was$4.93B (EPS $1.22).
The company ended the quarter with $5.18B in cash and short-term investments, a total debt of $18.02B, and net debt of $15.08B. Total assets were $59.01B, with equity of $12.80B. Financials further reflected stability, with operating cash flow of $6.35B, free cash flow of $4.00B, and capital expenditures of - $2.34B.

Price Forecast & Outlook

Our AI price prediction model suggests that GSK plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.86%, with price expected at $58.88 by April 16, 2026, within a range of $57.28 to $60.49 3-Month Outlook: Projected rise of 75.32%, reaching $99.39 by July 01, 2026, with a range of $97.54 to $101.80. 1-Year Outlook: Projected gain of 5.91%, with price at $60.04 by April 02, 2027, within a range of $58.63 to $61.86.

Key Takeaways

GSK plc (NYSE:GSK) shares are flat -2.83% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows GSK plc trading at a premium to the broader market with a P/E of 15.11. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $43.50, suggesting -23.27% downside. Our AI forecast model points to short-term strength (3.86% over two weeks), a medium-term rise (75.32% over three months), and a longer-term gain (5.91% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current GSK plc (GSK) stock price?

GSK plc (NYSE: GSK) stock price is $56.69 in the last trading session. During the trading session, GSK stock reached the peak price of $57.18 while $55.56 was the lowest point it dropped to. The percentage change in GSK stock occurred in the recent session was 1.25% while the dollar amount for the price change in GSK stock was $0.70.

GSK's industry and sector of operation?

The NYSE listed GSK is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. GSK plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GSK?

No Data

How GSK did perform over past 52-week?

GSK's closing price is 75.08% higher than its 52-week low of $32.38 where as its distance from 52-week high of $61.70 is -8.12%.

How many employees does GSK have?

Number of GSK employees currently stands at 68,629.

Link for GSK official website?

Official Website of GSK is: https://www.gsk.com

How do I contact GSK?

GSK could be contacted at phone 442 080 475000 and can also be accessed through its website. GSK operates from 980 Great West Road, Brentford, TW8 9GS, United Kingdom.

How many shares of GSK are traded daily?

GSK stock volume for the day was 3.54M shares. The average number of GSK shares traded daily for last 3 months was 5.59M.

What is the market cap of GSK currently?

The market value of GSK currently stands at $113.68B with its latest stock price at $56.69 and 2.01B of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	68629
Beta	0.32
Sales or Revenue	$30.33B
5Y Sales Change%	-0.045%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - General

GSK Company Profile and Key Details

GSK

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways